Cargando…

Parkinson’s disease-associated LRRK2-G2019S mutant acts through regulation of SERCA activity to control ER stress in astrocytes

Accumulating evidence indicates that endoplasmic reticulum (ER) stress is a common feature of Parkinson’s disease (PD) and further suggests that several PD-related genes are responsible for ER dysfunction. However, the underlying mechanisms are largely unknown. Here, we defined the mechanism by whic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jee Hoon, Han, Ji-hye, Kim, Hyunmi, Park, Sang Myun, Joe, Eun-hye, Jou, Ilo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498585/ https://www.ncbi.nlm.nih.gov/pubmed/31046837 http://dx.doi.org/10.1186/s40478-019-0716-4

Ejemplares similares

Small heterodimer partner (SHP) aggravates ER stress in Parkinson’s disease-linked LRRK2 mutant astrocyte by regulating XBP1 SUMOylation
por: Lee, Jee Hoon, et al.
Publicado: (2021)

5, 8, 11, 14-eicosatetraynoic acid suppresses CCL2/MCP-1 expression in IFN-γ-stimulated astrocytes by increasing MAPK phosphatase-1 mRNA stability
por: Lee, Jee Hoon, et al.
Publicado: (2012)

LRRK2 Inhibits FAK Activity by Promoting FERM-mediated Autoinhibition of FAK and Recruiting the Tyrosine Phosphatase, SHP-2
por: Choi, Insup, et al.
Publicado: (2016)

Astrocytes, Microglia, and Parkinson's Disease
por: Joe, Eun-Hye, et al.
Publicado: (2018)

LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase
por: Choi, Insup, et al.
Publicado: (2015)

Control of Inflammatory Responses: a New Paradigm for the Treatment of Chronic Neuronal Diseases
por: Woo, Joo Hong, et al.
Publicado: (2015)

DJ-1 deficiency impairs glutamate uptake into astrocytes via the regulation of flotillin-1 and caveolin-1 expression
por: Kim, Jin-Mo, et al.
Publicado: (2016)

Impaired Inflammatory Responses in Murine Lrrk2-Knockdown Brain Microglia
por: Kim, Beomsue, et al.
Publicado: (2012)

Suppression of miR-155 Expression in IFN-γ-Treated Astrocytes and Microglia by DJ-1: A Possible Mechanism for Maintaining SOCS1 Expression
por: Kim, Jong-hyeon, et al.
Publicado: (2014)

Kir4.1 is coexpressed with stemness markers in activated astrocytes in the injured brain and a Kir4.1 inhibitor BaCl(2) negatively regulates neurosphere formation in culture
por: Kwon, Jae-Kyung, et al.
Publicado: (2021)

Epigenetic downregulation of STAT6 increases HIF-1α expression via mTOR/S6K/S6, leading to enhanced hypoxic viability of glioma cells
por: Park, Soo Jung, et al.
Publicado: (2019)

Repair of astrocytes, blood vessels, and myelin in the injured brain: possible roles of blood monocytes
por: Jeong, Hey-Kyeong, et al.
Publicado: (2013)

PINK1 expression increases during brain development and stem cell differentiation, and affects the development of GFAP-positive astrocytes
por: Choi, Insup, et al.
Publicado: (2016)

PINK1 Deficiency Attenuates Astrocyte Proliferation Through Mitochondrial Dysfunction, Reduced AKT and Increased p38 MAPK Activation, and Downregulation of EGFR
por: Choi, Insup, et al.
Publicado: (2013)

Loss of parkin promotes lipid rafts-dependent endocytosis through accumulating caveolin-1: implications for Parkinson’s disease
por: Cha, Seon-Heui, et al.
Publicado: (2015)

Region-specific astrogliosis: differential vessel formation contributes to different patterns of astrogliosis in the cortex and striatum
por: Yang, Haijie, et al.
Publicado: (2020)

Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson’s Disease
por: Gaig, Carles, et al.
Publicado: (2014)

Sex differences in LRRK2 G2019S and idiopathic Parkinson's Disease
por: San Luciano, Marta, et al.
Publicado: (2017)

Erratum to: PINK1 expression increases during brain development and stem cell differentiation, and affects the development of GFAPpositive astrocytes
por: Choi, Insup, et al.
Publicado: (2016)

Differential Inhibition of LRRK2 in Parkinson's Disease Patient Blood by a G2019S Selective LRRK2 Inhibitor
por: Bright, Jessica M., et al.
Publicado: (2021)

Astrocytic atrophy as a pathological feature of Parkinson’s disease with LRRK2 mutation
por: Ramos-Gonzalez, Paula, et al.
Publicado: (2021)

G2019S Variation in LRRK2: An Ideal Model for the Study of Parkinson’s Disease?
por: Ren, Chao, et al.
Publicado: (2019)

STAT6 in mitochondrial outer membrane impairs mitochondrial fusion by inhibiting MFN2 dimerization
por: Kim, Hyunmi, et al.
Publicado: (2022)

Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
por: Streubel-Gallasch, Linn, et al.
Publicado: (2021)

Spread of neuronal degeneration in a dopaminergic, Lrrk-G2019S model of Parkinson disease
por: Hindle, Samantha J., et al.
Publicado: (2013)

Analysis of the LRRK2 p.G2019S mutation in Colombian Parkinson's Disease Patients
por: Duque, Andrés Felipe, et al.
Publicado: (2015)

LRRK2 G2019S Mutation: Prevalence and Clinical Features in Moroccans with Parkinson's Disease
por: Bouhouche, Ahmed, et al.
Publicado: (2017)

Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression
por: Ortega, Roberto A., et al.
Publicado: (2021)

Spatial and temporal correlation in progressive degeneration of neurons and astrocytes in contusion-induced spinal cord injury
por: Min, Kyoung-Jin, et al.
Publicado: (2012)

LRRK2 mutant knock-in mouse models: therapeutic relevance in Parkinson's disease
por: Chang, Eunice Eun Seo, et al.
Publicado: (2022)

Absence of Delayed Neuronal Death in ATP-Injected Brain: Possible Roles of Astrogliosis
por: Jeong, Hey-Kyeong, et al.
Publicado: (2013)

Neurite Collapse and Altered ER Ca(2+) Control in Human Parkinson Disease Patient iPSC-Derived Neurons with LRRK2 G2019S Mutation
por: Korecka, Joanna A., et al.
Publicado: (2018)

Modeling G2019S-LRRK2 Sporadic Parkinson's Disease in 3D Midbrain Organoids
por: Kim, Hongwon, et al.
Publicado: (2019)

Changes in Liver Lipidomic Profile in G2019S-LRRK2 Mouse Model of Parkinson’s Disease
por: Corral Nieto, Yaiza, et al.
Publicado: (2023)

An Assessment of LRRK2 Serine 935 Phosphorylation in Human Peripheral Blood Mononuclear Cells in Idiopathic Parkinson’s Disease and G2019S LRRK2 Cohorts
por: Padmanabhan, Shalini, et al.
Publicado: (2020)

LRRK2 Gly2019Ser Mutation Promotes ER Stress via Interacting with THBS1/TGF‐β1 in Parkinson's Disease
por: Yao, Longping, et al.
Publicado: (2023)

Role of LRRK2 variant p.Gly2019Ser in patients with Parkinsonism
por: Sadhukhan, Dipanwita, et al.
Publicado: (2020)

The G2019S LRRK2 Mutation is Rare in Korean Patients with Parkinson's Disease and Multiple System Atrophy
por: Cho, Jin-Whan, et al.
Publicado: (2009)

Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2(G2019S)-Parkinson’s disease
por: Juárez-Flores, Diana Luz, et al.
Publicado: (2018)

Pharmacological rescue of impaired mitophagy in Parkinson’s disease-related LRRK2 G2019S knock-in mice
por: Singh, Francois, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i1voorj13b9bucs21gp489ihhl